Chemist Sues University Again

Suvi Orr has filed suit against the University of Texas for the second time in two years in an attempt to prevent the school from revoking her PhD.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, DEREK KEYIn 2014, Pfizer chemist Suvi Orr sued the University of Texas at Austin, where she had earned her PhD in 2008, after the school pulled her degree due to the “falsified and misreported data” included in her dissertation. Now, according to a lawsuit filed last week (February 4) in state District Court in Travis County, the university is once again trying to revoke her degree, and Orr is once again suing to prevent the disciplinary action.

“Although the lawsuit refers to the plaintiff by those initials for privacy protections under federal law, the circumstances of the case leave no doubt that she is Orr,” the Austin American-Statesman reported.

Orr contends that she is being held accountable for the mistakes of her former advisor, University of Texas chemist Stephen Martin; both were authors on an Organic Letters paper that was retracted in 2011 after the chemical synthesis was unable to be reproduced, Retraction Watch reported this week (February 9). According to the latest suit, the school will hold a hearing next month in which three undergraduate students and two faculty members will deliberate on Orr’s case, but the suit argues that none of them “are qualified to evaluate the scientific evidence being ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies